Global Cell Therapy Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 101

Report ID: 3135

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.
In 2018, the global Cell Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy development in United States, Europe and China.

The key players covered in this study
Dendreon
Mesoblast
Vericel
Novartis AG
GlaxoSmithKline plc
MEDIPOST
Osiris
PHARMICELL
NuVasive, Inc.
JCR Pharmaceuticals Co., Ltd
ANTEROGEN.CO.,LTD.
Cynata
CELLECTIS
BioNTech IMFS
EUFETS GmbH
Cognate
Pluristem
Grupo Praxis
Genzyme Corporation
Advanced Tissue

Market segment by Type, the product can be split into
Autologous
Allogeneic

Market segment by Application, split into
Hospitals and clinics
ASCs
Regenerative medicine centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cell Therapy status, future forecast, growth opportunity, key market and key players.
To present the Cell Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cell Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cell Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Autologous
1.4.3 Allogeneic
1.5 Market by Application
1.5.1 Global Cell Therapy Market Share by Application (2014-2025)
1.5.2 Hospitals and clinics
1.5.3 ASCs
1.5.4 Regenerative medicine centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cell Therapy Market Size
2.2 Cell Therapy Growth Trends by Regions
2.2.1 Cell Therapy Market Size by Regions (2014-2025)
2.2.2 Cell Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cell Therapy Market Size by Manufacturers
3.1.1 Global Cell Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Cell Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Cell Therapy Key Players Head office and Area Served
3.3 Key Players Cell Therapy Product/Solution/Service
3.4 Date of Enter into Cell Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cell Therapy Market Size by Type (2014-2019)
4.2 Global Cell Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Cell Therapy Market Size (2014-2019)
5.2 Cell Therapy Key Players in United States
5.3 United States Cell Therapy Market Size by Type
5.4 United States Cell Therapy Market Size by Application

6 Europe
6.1 Europe Cell Therapy Market Size (2014-2019)
6.2 Cell Therapy Key Players in Europe
6.3 Europe Cell Therapy Market Size by Type
6.4 Europe Cell Therapy Market Size by Application

7 China
7.1 China Cell Therapy Market Size (2014-2019)
7.2 Cell Therapy Key Players in China
7.3 China Cell Therapy Market Size by Type
7.4 China Cell Therapy Market Size by Application

8 Japan
8.1 Japan Cell Therapy Market Size (2014-2019)
8.2 Cell Therapy Key Players in Japan
8.3 Japan Cell Therapy Market Size by Type
8.4 Japan Cell Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cell Therapy Market Size (2014-2019)
9.2 Cell Therapy Key Players in Southeast Asia
9.3 Southeast Asia Cell Therapy Market Size by Type
9.4 Southeast Asia Cell Therapy Market Size by Application

10 India
10.1 India Cell Therapy Market Size (2014-2019)
10.2 Cell Therapy Key Players in India
10.3 India Cell Therapy Market Size by Type
10.4 India Cell Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Cell Therapy Market Size (2014-2019)
11.2 Cell Therapy Key Players in Central & South America
11.3 Central & South America Cell Therapy Market Size by Type
11.4 Central & South America Cell Therapy Market Size by Application

12 International Players Profiles
12.1 Dendreon
12.1.1 Dendreon Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cell Therapy Introduction
12.1.4 Dendreon Revenue in Cell Therapy Business (2014-2019)
12.1.5 Dendreon Recent Development
12.2 Mesoblast
12.2.1 Mesoblast Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cell Therapy Introduction
12.2.4 Mesoblast Revenue in Cell Therapy Business (2014-2019)
12.2.5 Mesoblast Recent Development
12.3 Vericel
12.3.1 Vericel Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cell Therapy Introduction
12.3.4 Vericel Revenue in Cell Therapy Business (2014-2019)
12.3.5 Vericel Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cell Therapy Introduction
12.4.4 Novartis AG Revenue in Cell Therapy Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 GlaxoSmithKline plc
12.5.1 GlaxoSmithKline plc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cell Therapy Introduction
12.5.4 GlaxoSmithKline plc Revenue in Cell Therapy Business (2014-2019)
12.5.5 GlaxoSmithKline plc Recent Development
12.6 MEDIPOST
12.6.1 MEDIPOST Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cell Therapy Introduction
12.6.4 MEDIPOST Revenue in Cell Therapy Business (2014-2019)
12.6.5 MEDIPOST Recent Development
12.7 Osiris
12.7.1 Osiris Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cell Therapy Introduction
12.7.4 Osiris Revenue in Cell Therapy Business (2014-2019)
12.7.5 Osiris Recent Development
12.8 PHARMICELL
12.8.1 PHARMICELL Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cell Therapy Introduction
12.8.4 PHARMICELL Revenue in Cell Therapy Business (2014-2019)
12.8.5 PHARMICELL Recent Development
12.9 NuVasive, Inc.
12.9.1 NuVasive, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cell Therapy Introduction
12.9.4 NuVasive, Inc. Revenue in Cell Therapy Business (2014-2019)
12.9.5 NuVasive, Inc. Recent Development
12.10 JCR Pharmaceuticals Co., Ltd
12.10.1 JCR Pharmaceuticals Co., Ltd Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cell Therapy Introduction
12.10.4 JCR Pharmaceuticals Co., Ltd Revenue in Cell Therapy Business (2014-2019)
12.10.5 JCR Pharmaceuticals Co., Ltd Recent Development
12.11 ANTEROGEN.CO.,LTD.
12.12 Cynata
12.13 CELLECTIS
12.14 BioNTech IMFS
12.15 EUFETS GmbH
12.16 Cognate
12.17 Pluristem
12.18 Grupo Praxis
12.19 Genzyme Corporation
12.20 Advanced Tissue

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details